CommentaryCancer

One Foundation’s Strategy to Accelerate Drug Discovery Through Genomics

See allHide authors and affiliations

Science Translational Medicine  13 Apr 2011:
Vol. 3, Issue 78, pp. 78cm11
DOI: 10.1126/scitranslmed.3002440

Figures

  • Fig. 1.

    Fighting a rare disease. Shown are multiple myeloma cells (malignant mature B lymphocytes) adhering to fibronectin (red, actin; blue, nucleus; green, phosphorylated focal adhesion kinase).

    Credit: IMAGE COURTESY OF MATTHEW BRENTNALL/PAOLA NERI

Navigate This Article